Author:
Khan Mohsin Ali,Siddiqui Sahabjada,Ahmad Imran,Singh Romila,Mishra Durga Prasad,Srivastava Anand Narain,Ahmad Rumana
Abstract
AbstractAjwa dates (Phoenix dactylifera L.) have been described in traditional and alternative medicine to provide several health benefits, but their mechanism of apoptosis induction against human triple-negative breast cancer MDA-MB-231 cells remains to be investigated. In this study, we analyzed the phytoconstituents in ethanolic Ajwa Dates Pulp Extract (ADPE) by liquid chromatography-mass spectrometry (LC–MS) and investigated anticancer effects against MDA-MB-231 cells. LC–MS analysis revealed that ADPE contained phytocomponents belonging to classes such as carbohydrates, phenolics, flavonoids and terpenoids. MTT assay demonstrated statistically significant dose- and time-dependent inhibition of MDA-MB-231 cells with IC50 values of 17.45 and 16.67 mg/mL at 24 and 48 h, respectively. Hoechst 33342 dye and DNA fragmentation data showed apoptotic cell death while AO/PI and Annexin V-FITC data revealed cells in late apoptosis at higher doses of ADPE. More importantly, ADPE prompted reactive oxygen species (ROS) induced alterations in mitochondrial membrane potential (MMP) in ADPE treated MDA-MB-231 cells. Cell cycle analysis demonstrated that ADPE induced cell arrest in S and G2/M checkpoints. ADPE upregulated the p53, Bax and cleaved caspase-3, thereby leading to the downregulation of Bcl-2 and AKT/mTOR pathway. ADPE did not show any significant toxicity on normal human peripheral blood mononuclear cells which suggests its safe application to biological systems under study. Thus, ADPE has the potential to be used as an adjunct to the mainline of treatment against breast cancer.
Publisher
Springer Science and Business Media LLC
Reference37 articles.
1. Fitzmaurice, C. et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncol. 3(4), 524–548 (2017).
2. https://seer.cancer.gov/statfacts/html/breast.html/ (Access on March 05, 2020).
3. https://www.oncostem.com/blog/alarming-facts-about-breast-cancer-in-india/ (Access on March 10, 2020).
4. Malvia, S., Bagadi, S. A., Dubey, U. S. & Saxena, S. Epidemiology of breast cancer in Indian women. Asian Pac. J. Clin. Oncol. 13(4), 289–295 (2017).
5. Arruebo, M. et al. Assessment of the evolution of cancer treatment therapies. Cancers 3(3), 3279–3330 (2011).
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献